Dr. Sarnak is Chief of the Division of Nephrology and Professor of Medicine at Tufts University School of Medicine (TUSM). His research focuses on cardiovascular disease and its risk factors in chronic kidney disease (CKD), aging and kidney disease, cognitive function and CKD, and novel biomarkers of CKD. Dr. Sarnak’s research is funded by the National Institutes of Health. Dr. Sarnak is a previous recipient of the Shaul Massry Distinguished Lecture Award from the National Kidney Foundation and the Distinguished Faculty Award from TUSM. Dr. Sarnak’s clinical specialties are in cardiovascular disease in patients with kidney disease, management of CKD, dialysis, hypertension, kidney transplantation, and kidney stones. He recently chaired the Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference for Coronary Artery Disease and Valvular Disease in Kidney Disease and was a member of the Steering Committee for both the KDIGO Controversies Conference on Heart Failure in CKD and Blood Pressure in CKD. He was a member of the KDIGO Kidney Blood Pressure Guideline Update that took place in 2019-2020, which will be published in 2021. He is Chair of the Cardiovascular Impact of Home Dialysis Therapies in Patients with End Stage Kidney Disease: A Scientific Statement from the American Heart Association, which will take place in 2021-2022.